Fatigue in sarcoidosis is variable and may be associated to Vitamin D

I. Papanikolaou (Corfu, Greece), I. Makou (Corfu, Greece), E. Antonakis (Corfu, Greece), K. Pagratis (Corfu, Greece), A. Afthinos (Corfu, Greece)

Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Session: Sarcoidosis: a multifaceted disease that is difficult to manage
Session type: Thematic Poster
Number: 1377
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Papanikolaou (Corfu, Greece), I. Makou (Corfu, Greece), E. Antonakis (Corfu, Greece), K. Pagratis (Corfu, Greece), A. Afthinos (Corfu, Greece). Fatigue in sarcoidosis is variable and may be associated to Vitamin D. 1377

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vitamin D deficiency and activity of sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Relationship between Vitamin D and severity in COPD patients
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Vitamin D and Bronchiectasis Severity Index (BSI): A correlation
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018


Vitamin D deficiency and exacerbation frequency in COPD
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Vitamin D deficiency and FEV1 decline in COPD
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Asthma and vitamin D
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012

Vitamin D as a marker of worsening of the course of pneumonia.
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Vitamin D concentration and patient reported outcomes in sarcoidosis
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015


Risk of bacterial infection in COPD patients with Vitamin D defficiency
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019

Diet related vitamin D deficiency and reactivation of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 416s
Year: 2004

Clinical impact of vitamin D deficiency on Tunisian asthmatics
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Vitamin D deficiency is very common in London tuberculosis contacts
Source: Eur Respir J 2004; 24: Suppl. 48, 34s
Year: 2004

Persistent chronic cough and vitamin D deficiency
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021



Vitamin D receptor and vitamin D binding protein polymorphisms are associated with asthma control in children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Vitamin D receptor polymorphisms and exacerbation frequency in COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Predictive factors of vitamin D status in southern-mediterranean patients with COPD
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Association of vitamin D deficiency with COPD and vitamin D binding proteins
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009


Vitamin D status and its relationships with bone density in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 43s
Year: 2006

Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Vitamin D binding protein: a new biomarker of disease severity in lymphangioleiomyomatosis
Source: Eur Respir J, 52 (5) 1801886; 10.1183/13993003.01886-2018
Year: 2018